Global WholeHealth Partners Corp Partners with Nunzia Pharmaceutical Inc., Opening New Global Avenues of Revenue and Products
San Clemente, CA – April 20, 2021 – Global WholeHealth Partners Corp (OTC Pink: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests attains breakthrough on rising neurological disease. “We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for […]
A Medical Breakthrough Attained by Global WholeHealth Partners, Corp as a Leading Researcher, Believes a Dementia Diagnostics Test will save Lives
San Clemente, CA – April 20, 2021 – Global WholeHealth Partners Corp (OTC: GWHP), a multinational supplier of over 70+ FDA Approved Diagnostic Tests attains breakthrough on rising neurological disease. Global WholeHealth Partners now has the means to identify and test for Dementia using a Micro-Well Reader or Lateral Flow Test to measure the […]
Global WholeHealth Partners, Corp Describes the Pros and Cons of the Common Types of COVID-19 Test Kits Available
San Clemente, CA – November 17, 2020 – Global WholeHealth Partners Corporation (OTCPK: GWHP) announces the coronavirus disease 2019 (COVID-19) pandemic has placed the world in a tailspin, which the healthcare industry has responded to in kind with the development and rapid deployment of tests designed to detect infection. Many of these tests help clinicians […]
Global Whole Health Partners Corp. (GWHP) Announces It now offers the new FDA cleared “Fingerstick” for rapid COVID-19 test results in minutes
San Clemente, CA – November 5, 2020 – Global WholeHealth Partners Corp. (OTC MKTS: GWHP) a developer, manufacturer and provider of Made in the USA Covid-19 Rapid Test Kits based in San Clemente, CA announces it offers the New “Fingerstick” For Rapid COVID-19 Test Results in Minutes with FDA Clearance for Emergency Use, by partnering […]
Global WholeHealth Partners Corp. (GWHP): The Commentary for Submitting the (EUA) Application # PEUA201789 Date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as Mentioned in the 8K Filing on 09/15/20
San Clemente, CA – October. 29, 2020 – Global WholeHealth Partners Corp. (OTC MKTS: GWHP): The Antigen CoViD19 will be a point-of-care settings, like a doctor’s office, emergency room, or some schools. This test has been authorized for use in patients suspected of COVID-19 by their healthcare provider within seven days of symptom onset. Given the […]
